Literature DB >> 24525528

Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.

Gokcen Dinc1, Hayati Demiraslan, Ferhan Elmali, Salman Shaheer Ahmed, Gokhan Metan, Emine Alp, Mehmet Doganay.   

Abstract

BACKGROUND: In recent years, multidrug-resistant Acinetobacter baumannii has been reported as an important nosocomial pathogen, and treatment options are limited. The aim of this study was to investigate the additional effect of sulbactam on monotherapy with colistin, tigecycline and imipenem in experimental sepsis with carbapenem-resistant A. baumannii in mice.
METHODS: Sepsis was developed in 8- to 10-week-old BALB/c mice by an intraperitoneal injection of A. baumannii. Antibiotic was given intraperitoneally 2 h after bacterial inoculation. Each experimental group had 15 mice and was divided into 3 subgroups. Mice were sacrificed at 24, 48 or 72 h. Lung, liver, heart and spleen samples were cultured, and homogenates of lung and liver were used to detect the number of colony-forming units per gram. Bacterial clearance was compared in lung and liver at different time points.
RESULTS: Imipenem did not decrease the bacterial load, but the other antibiotics showed significant bactericidal activity compared with the control group, and the combination of imipenem with sulbactam decreased the bacterial load in lung and liver. However, the addition of sulbactam to colistin and tigecycline had no significant effect on bacterial counts. Only the addition of sulbactam to imipenem showed better bactericidal activity compared to imipenem alone.
CONCLUSIONS: These results suggested that combining sulbactam with tigeycline or colistin does not increase the efficiency of these antibiotics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24525528     DOI: 10.1159/000356755

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  10 in total

1.  Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.

Authors:  Zubair A Qureshi; Lauren E Hittle; Jessica A O'Hara; Jesabel I Rivera; Alveena Syed; Ryan K Shields; Anthony W Pasculle; Robert K Ernst; Yohei Doi
Journal:  Clin Infect Dis       Date:  2015-01-28       Impact factor: 9.079

2.  Genetic Variability of AdeRS Two-Component System Associated with Tigecycline Resistance in XDR-Acinetobacter baumannii Isolates.

Authors:  S Montaña; E Vilacoba; G M Traglia; M Almuzara; M Pennini; A Fernández; A Sucari; D Centrón; M S Ramírez
Journal:  Curr Microbiol       Date:  2015-05-05       Impact factor: 2.188

Review 3.  Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.

Authors:  Bora Shin; Woojun Park
Journal:  J Microbiol       Date:  2017-10-27       Impact factor: 3.422

4.  In vitro and in vivo analysis of antimicrobial agents alone and in combination against multi-drug resistant Acinetobacter baumannii.

Authors:  Songzhe He; Hui He; Yi Chen; Yueming Chen; Wei Wang; Daojun Yu
Journal:  Front Microbiol       Date:  2015-05-27       Impact factor: 5.640

5.  Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii.

Authors:  Fatih Temocin; Fatma Sebnem Erdinc; Necla Tulek; Meryem Demirelli; Gunay Ertem; Sami Kinikli; Eda Koksal
Journal:  Braz J Microbiol       Date:  2015 Oct-Dec       Impact factor: 2.476

6.  Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.

Authors:  Taylor Abbey; Alesia Vialichka; Michele Jurkovic; Mark Biagi; Eric Wenzler
Journal:  Microbiol Spectr       Date:  2022-06-01

Review 7.  Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?

Authors:  Song Oh; Raymond Chau; Anh T Nguyen; Justin R Lenhard
Journal:  Antibiotics (Basel)       Date:  2021-05-28

8.  Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria.

Authors:  Phillip J Bergen; Zackery P Bulman; Cornelia B Landersdorfer; Nicholas Smith; Justin R Lenhard; Jürgen B Bulitta; Roger L Nation; Jian Li; Brian T Tsuji
Journal:  Infect Dis Ther       Date:  2015-12-08

9.  Antimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis.

Authors:  Maryam Pourhajibagher; Farhad B Hashemi; Babak Pourakbari; Masoud Aziemzadeh; Abbas Bahador
Journal:  Open Microbiol J       Date:  2016-03-29

10.  Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.

Authors:  Bing Fan; Jie Guan; Xiumei Wang; Yulong Cong
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.